Downloadable and recorded digital storage media; training manuals in electronic form; software; web applications; software and software platforms for modelling and simulation, in particular in the field of pharmacy, chemistry or plant protection; modelling and simulation software and platforms for PBPK [physiologically-based pharmacokinetics] and QSP [quantitative systems pharmacology]; software and software platforms for investigating organ damage; software and software platforms for investigating drug-drug interactions (DDI); software and software platforms for translational modelling for human initial dose prediction; software and software platforms for developing, calculating and analysing mathematical models and simulations, in particular in the field of life sciences; software and software platforms with graphical user interfaces for various operating systems and platforms; software and software platforms for solving numerical problems; software and software platforms for analysing data, in particular statistically; software and software platforms for graphical visualisation of simulation results and observed data; software packages for programming languages; databases.

Education, training and teaching; training and education services; organisation and provision of training courses; organisation and provision of training courses, conferences, workshops and seminars relating to software and software platforms for modelling and simulation, in particular in the field of pharmacy, chemistry or plant protection; organisation and provision of training courses, conferences, workshops and seminars relating to PBPK (physiologically-based pharmacokinetics) and QSP (quantitative systems pharmacology) modelling and simulation software and platforms; organisation and provision of training courses, conferences, workshops and seminars relating to the development of preclinical or clinical PBPK software models; organisation and provision of training courses, conferences, workshops and seminars relating to software and software platforms for investigating organ damage; organisation and provision of training courses, conferences, workshops and seminars relating to software and software platforms for investigating drug-drug interactions (DDI); organisation and provision of training courses, conferences, workshops and seminars relating to software and software platforms for translational modelling for initial dose prediction in humans; organisation and provision of training courses, conferences, workshops and seminars relating to software and software platforms for the development, calculation and analysis of mathematical models and simulations, in particular in the field of life sciences; organisation and provision of training courses, conferences, workshops and seminars relating to software and software platforms with graphical user interfaces for various operating systems and platforms; organisation and provision of training courses, conferences, workshops and seminars relating to software and software platforms for solving numerical problems; organisation and provision of training courses, conferences, workshops and seminars relating to software and software platforms for the statistical evaluation of data; organisation and provision of training courses, conferences, workshops and seminars relating to software and software platforms for the graphical representation of simulation results and observed data; organisation and provision of training courses, conferences, workshops and seminars relating to the development and implementation of packages for programming languages; organisation and provision of training courses, conferences, workshops and seminars relating to the creation and integration of databases; creation of training materials; creation of training materials relating to software and software platforms for modelling and simulation, in particular in the field of pharmacy, chemistry or plant protection; creation of training materials relating to PBPK (physiologically-based pharmacokinetics) and QSP (quantitative systems pharmacology) modelling and simulation software and platforms; creation of training materials relating to the development of preclinical or clinical PBPK software models; creation of training materials relating to software and software platforms for studying organ damage; creation of training materials relating to software and software platforms for the study of drug-drug interactions (DDI); creation of training materials relating to software and software platforms for translational modelling for human initial dose prediction; creation of training materials relating to software and software platforms for developing, calculating and analysing mathematical models and simulations, in particular in the field of life sciences; creation of training materials relating to software and software platforms with graphical user interfaces for different operating systems and platforms; creation of training materials relating to software and software platforms for solving numerical problems; creation of training materials relating to software and software platforms for statistical analysis of data; creation of training materials relating to software and software platforms for the graphical visualisation of simulation results and observed data; creation of training materials relating to the development and implementation of packages for programming languages; creation of training materials relating to the creation and integration of databases.

Scientific and technological services and research and related design services; industrial analysis, industrial research and industrial design services; quality control and authentication services; IT services; software as a service [SaaS]; platform as a service [PaaS]; computer services for data analyses; conducting of technical data analyses; design, development, programming and implementation of software; design, development, programming and implementation of software platforms; design, development, programming and implementation of software and software platforms for modelling and simulation, in particular in the field of pharmacy, chemistry or plant protection; design, development, programming and implementation of PBPK (physiologically-based pharmacokinetics) and QSP (quantitative systems pharmacology) modelling and simulation software and platforms; design, development, programming and implementation of software and software platforms for the development of preclinical or clinical PBPK software models; design, development, programming and implementation of software and software platforms for investigating organ damage; design, development, programming and implementation of software and software platforms for investigating drug-drug interactions (DDI); design, development, programming and implementation of software and software platforms for translational modelling for human initial dose prediction; design, development, programming and implementation of software and software platforms for the development, calculation and analysis of mathematical models and simulations, in particular in the field of life sciences; design, development, programming and implementation of software and software platforms with graphical user interfaces for various operating systems and platforms; design, development, programming and implementation of software and software platforms for solving numerical problems; design, development, programming and implementation of software and software platforms for statistical analysis of data; design, development, programming and implementation of software and software platforms for the graphical visualisation of simulation results and observed data; design, development, programming and implementation of packages for programming languages; design, development, programming and implementation of databases; provision of temporary use of non-downloadable software and software platforms; provision of temporary use of non-downloadable software and software platforms for modelling and simulation, in particular in the field of pharmacy, chemistry or plant protection; provision of temporary use of non-downloadable PBPK (physiologically-based pharmacokinetics) and QSP (quantitative systems pharmacology) modelling and simulation software and platforms, in particular in the field of pharmacy, chemistry or plant protection; provision of temporary use of non-downloadable software and software platforms for the development of preclinical or clinical PBPK software models; provision of temporary use of non-downloadable software and software platforms for the investigation of organ damage; provision of temporary use of non-downloadable software and software platforms for investigating drug-drug interactions (DDI); provision of temporary use of non-downloadable software and software platforms for translational modelling for human initial dose prediction; provision of temporary use of non-downloadable software and software platforms for the development, calculation and analysis of mathematical models and simulations, in particular in the field of life sciences; provision of temporary use of non-downloadable software and software platforms with graphical user interfaces for various operating systems and platforms; provision of temporary use of non-downloadable software and software platforms for solving numerical problems; provision of temporary use of non-downloadable software and software platforms for analysing data, in particular statistically; provision of temporary use of non-downloadable software and software platforms for graphical visualisation of simulation results and observed data; technological and scientific consulting services; IT consultancy, advisory and information services; IT consultancy, advisory and information services relating to software and software platforms for modelling and simulation, in particular in the field of pharmacy, chemistry or plant protection; IT consultancy, advisory and information services relating to PBPK (physiologically-based pharmacokinetics) and QSP (quantitative systems pharmacology) modelling and simulation software and platforms, in particular in the field of pharmacy, chemistry or plant protection; IT consultancy, advisory and information services relating to software and software platforms for the development of preclinical or clinical PBPK software models; IT consultancy, advisory and information services relating to software and software platforms for studying organ damage; IT consultancy, advisory and information services relating to software and software platforms for investigating drug-drug interactions (DDI); IT consultancy, advisory and information services relating to software and software platforms for translational modelling for human initial dose prediction; IT consultancy, advisory and information services relating to software and software platforms for the development, calculation and analysis of mathematical models and simulations, in particular in the field of life sciences; IT consultancy, advisory and information services relating to software and software platforms with graphical user interfaces for various operating systems and platforms; IT consultancy, advisory and information services relating to software and software platforms for solving numerical problems; IT consultancy, advisory and information services relating to software and software platforms for analysing data, in particular statistically; IT consultancy, advisory and information services relating to software and software platforms for the graphical visualisation of simulation results and observed data; IT consultancy, advisory and information services relating to the development and implementation of packages for programming languages; IT consultancy, advisory and information services relating to the creation and integration of databases; installation, setting up and maintenance of software; installation, setting up and maintenance of software and software platforms for modelling and simulation, in particular in the field of pharmacy, chemistry or plant protection; installation, setting up and maintenance of PBPK (physiologically-based pharmacokinetics) and QSP (quantitative systems pharmacology) modelling and simulation software and platforms; installation, setting up and maintenance of software and software platforms for the development of preclinical or clinical PBPK software models; installation, setting up and maintenance of software and software platforms for investigating organ damage; installing, setting up and maintenance of software and software platforms for investigating drug-drug interactions (DDI); installation, setting up and maintenance of software and software platforms for translational modelling for human initial dose prediction; installing, setting up and maintenance of software and software platforms for developing, calculating and analysing mathematical models and simulations, in particular in the field of life sciences; installing, setting up and maintenance of software and software platforms with graphical user interfaces for various operating systems and platforms; installing, setting up and maintenance of software and software platforms for solving numerical problems; installing, setting up and maintenance of software and software platforms for analysing data, in particular statistically; installing, setting up and maintenance of software and software platforms for the graphical visualisation of simulation results and observed data; installation, setting up and maintenance of packages for programming languages; installation, setting up and maintenance of databases; medical and pharmaceutical research services.